Elevated expression of SAG/ROC2/Rbx2/Hrt2 in human colon carcinomas: SAG does not induce neoplastic transformation, but antisense SAG transfection inhibits tumor cell growth

Molecular Carcinogenesis

Volumn 30, Issue 1, 2001, Pages 62-70

  Huang, Yuanhui ^a   Duan, Hangjun ^a   Sun, Yi ^a  

^a PFIZER INC   (United States)

Author keywords

Antisense transfection; Colon carcinomas; Neoplastic transformation; Sensitive to apoptosis gene; Skp1, Cdc53 Cull, F box protein; Tumor cell growth inhibition

Indexed keywords

GENE PRODUCT; PROTEIN HRT2; PROTEIN RBX2; PROTEIN ROC2; PROTEIN SAG; UNCLASSIFIED DRUG;

ANIMAL CELL; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER INHIBITION; COLON CARCINOMA; CONTROLLED STUDY; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; MALIGNANT TRANSFORMATION; MOUSE; NONHUMAN; NUCLEIC ACID PROBE; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ANIMALS; CELL DIVISION; CELL LINE; CELL TRANSFORMATION, NEOPLASTIC; COLONIC NEOPLASMS; ENZYME INHIBITORS; HUMANS; MICE; MICROFILAMENT PROTEINS; MUSCLE PROTEINS; OLIGONUCLEOTIDES, ANTISENSE; PHENOTYPE; RECOMBINANT FUSION PROTEINS; TRANSFECTION;

EID: 0035145738     PISSN: 08991987     EISSN: None     Source Type: Journal    
DOI: 10.1002/1098-2744(200101)30:1<62::AID-MC1014>3.0.CO;2-A     Document Type: Article

References (35)

1. Cyclins and cancer II: Cyclin D and CDK inhibitors come of age
2. The action of oncogenes in the cytoplasm and nucleus
3. A genetic model for colorectal tumorigenesis
4. Cell cycle control and cancer
5. Inhibitors of mammalian G1 cyclin-dependent kinases
6. How proteolysis drives the cell cycle
7. The ubiquitin-mediated proteolytic pathway as a therapeutic area
8. The ubiquitin-proteasome pathway: On protein death and cell life
9. SAG, a novel zinc RING finger protein that protects cells from apoptosis induced by redox agents
10. Expression, purification, and biochemical characterization of SAG, a RING finger redox sensitive protein
11. Yeast homolog of human SAG/ROC2/Rbx2/Hrt2 is essential for cell growth, but not for germination: Chip profiling implicates its role in cell cycle regulation
12. Rbx1, a component of the VHL tumor suppressor complex and SCF ubiquitin ligase
13. ROC 1, a homolog of APC11, represents a family of cullin partners with an associated ubiquitin ligase activity
14. Recruitment of a ROC1-CUL1 ubiquitin ligase by Skp1 and HOS to catalyze the ubiquitination of IkBa
15. Cdc53/cullin and the essential Hrt1 RING-H2 subunit of SCF define a ubiquitin ligase module that activates the E2 enzyme Cdc34
16. Promotion of the S-phase entry and cell growth under serum starvation by SAG/ROC2/Rbx2/Hrt2, an E3 ubiquitin ligase component: Association with inhibition of p27 accumulation
17. Progression toward tumor cell phenotype is enhanced by overexpression of a mutant p53 tumor-suppressor gene isolated from nasopharyngeal carcinoma
18. Acquisition of a growth-inhibitory response to phorbol ester involves DNA damage
19. No point mutation of Ha-ras or p53 genes expressed in preneoplastic-to-neoplastic progression as modeled in mouse JB6 cell variants
20. Alteration of SAG mRNA in human cancer cell lines: Requirement for the RING finger domain for apoptosis protection
21. Phorbol esters stimulate DNA synthesis and ornithine decarboxylase activity in mouse epidermal cell cultures
22. Responses of preneoplastic epidermal cells to tumor promoters and growth factors: Use of promoter-resistant variants for mechanism studies
23. SKP1 connects cell cycle regulators to the ubiquitin proteolysis machinery through a novel motif, the F-box
24. F-box proteins are receptors that recruit phosphorylated substrates to the SCF ubiquitin-ligase complex
25. Ubiquitination of p27 is regulated by Cdk-dependent phosphorylation and trimeric complex formation
26. skp2 complex through phosphorylated Thr187 in p27
27. SKP2 is required for ubiquitin-mediated degradation of the CDK inhibitor p27
28. p45SKP2 promotes p27Kip1 degradation and induces S phase in quiescent cells
29. Decreased levels of the cell-cycle inhibitor p27Kip1 protein: Prognostic implications in primary breast cancer
30. Reduced expression of the cell cycle inhibitor p27Kip1 in non - Small cell lung carcinoma: A prognostic factor independent of Ras
31. Increased proteasome-dependent degradation of the cyclin-dependent kinase inhibitor p27 in aggressive colorectal carcinomas
32. Association with cullin partners protects ROC proteins from proteasone-dependent degradation
33. The human homologue for the Caenorhabditis elegans cul-4 gene is amplified and overexpressed in primary breast cancers
34. p19Skp1 and p45Skp2 are essential elements of the cyclin A-CDK2 S phase kinase
35. Role of the ubiquitin-proteasome pathway in regulating abundance of the cyclin-dependent kinase inhibitor p27